Dig into the latest cell therapy research and best practices to advance patient care

In the Explore Cell Therapy podcast, we examine practice-changing research and hot topics in hematopoietic stem cell transplantation (HCT) and other cellular therapies. You'll hear conversations with well-known and up-and-coming physicians who specialize in HCT and physicians at hematology/oncology practices.

Our goal is to bring you enlightening insights to help you advance care for patients with hematologic malignancies and disorders.

Explore Cell Therapy Podcast: Season 2 Episode Recaps

Access a written recap with additional resources and short clips of each Explore Cell Therapy episode.

HCT Across MDS Genetic Subtypes (S2 E14)
Part 1: Expanding Access to Older Patients
Part 2: The Role of Genetics and Early Consult

In this two-part "Explore Cell Therapy" podcast episode, Coleman Lindsley, MD, PhD, and Corey Cutler, MD, MPH, FRCP(C), discuss recent and evolving research supporting the broad benefits of hematopoietic cell transplant (HCT) across all genetic subtypes of myelodysplastic syndrome (MDS), including for patients with high-risk mutations like TP53.

Overcoming Challenges in Cell & Gene Therapy Clinical Trials (S2 E6)
Part 1: Study Design and Recruitment
Part 2: Cost and Collaboration

This two-part episode features a panel discussion from Advanced Therapies Week 2023, a conference focused on advancing cell and gene therapy. In a session sponsored by NMDP BioTherapies® and moderated by Chris McClain, MBA, Heather Stefanski, MD, PhD, Erin Leckrone, MBA, and Gabbi Giammarino, BS, they discuss the current state of the cell and gene therapy industry to ramp up clinical trials and expand access to care.

State of the Science in Ensuring a Donor for All (S2 E5)
Part 1: Donor Availability and Addressing Barriers
Part 2: Donor Optimization and Looking to the Future

In this two-part episode, Stephen Spellman, MBS, and Jeffrey Auletta, MD, with NMDP and the CIBMTR® (Center for International Blood and Marrow Transplantation Research) discuss the current state of the science in finding an optimal donor for all patients in need of allogeneic hematopoietic cell transplantation.

Structural Racism and AML (S2 E4)
Part 1: The Impact of Structural Racism on AML Outcomes
Part 2: Addressing Barriers and Equity Across Health Care Teams

In this two-part episode, Irum Khan, MD, from the University of Illinois Cancer Center and Jonathan Moreira, MD, a transplant physician from Northwestern University Feinberg School of Medicine, discuss novel research on the impact of structural racism on acute myeloid leukemia (AML) outcomes for underserved communities and ethnically diverse patients in the Chicago area.

Evidence for Shared Care in HCT (S2 E3)
Part 1: The Impact of Sharing Care and Timing
Part 2: Addressing Barriers and Equity with Shared Care

In this two-part episode, Wendy Woods (formally Woods-Swafford), MD, MPH of Blank Children's Hospital, and Heather Stefanski, MD, PhD of NMDP join Kelley Steffens, principal investigator and research manager at NMDP, to discuss recent research supporting strong relationships between hematology/oncology and transplant center care teams.<

Overcoming Barriers to HCT and Improving Access (S2 E2)
Part 1: Barriers in HCT and the Importance of Time
Part 2: Health Equity, Solutions and Building Trust via Shared Care

In this two-part episode, Karen Ballen, MD, of University of Virginia Health, and Mitul Gandhi, MD, of Virginia Cancer Specialists, discuss recent research around access to HCT, as well as overcoming HCT barriers through coordinated care between transplant centers and hematology/oncology practices.

Advances in HCT Over Time (S2 E1)
Part 1: Transplant Then and Now
Part 2: Donor Availability, Graft Sources and the Birth of the NMDP
Part 3: Persistent Misconceptions, Coordinated Care and the Future of HCT

The three-part Advances in HCT Over Time episode follows a discussion of the current state of HCT science by exploring the evolution of HCT. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology, discuss HCT from a research and practice perspective at the transplant center and hematology/oncology practice level.

Never miss an episode!

Sign up to be the first to know when a new episode is released.